Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Inhalytic Ltd is a pharmaceutical analytical services company located at Sandwich Discovery Park in Kent, UK, focused on orally inhaled and nasal drug products (OINDPs). Based on the website content, it is more of a specialized CRO/consulting laboratory than a SaaS or enterprise software provider. The company highlights over 100 years of pharmaceutical experience and provides analytical testing, method development, project consulting, and training for inhalation formulation development teams.
Its services cover a fairly complete analytical workflow for inhalation product development, including performance testing such as Impactor Testing, Emitted Dose Testing, and Spacer Performance Evaluation; IVIVC-related oropharyngeal models, breathing simulation, and dissolution studies; as well as method and technology development for Plume Geometry/Spray Pattern, spacer testing methods, pMDI total canister content, and Karl Fischer testing. For stability, the website lists ICH-condition stability, ASAP, forced degradation and impurities, and extractables and leachables studies. It also offers 3D-printed rapid prototyping, data interpretation, project management, analytical troubleshooting, CRO/CMO selection and oversight, and customized training.
The website does not disclose packages, pricing, free trials, or standard service timelines. Pricing is likely customized via the contact form or by phone. Payment methods are also not specified.
The main advantages are its strong vertical specialization and team members with backgrounds at AstraZeneca, Mylan, Pfizer, and others. Its services extend from laboratory testing to project consulting, making it suitable for complex inhalation formulation development. The drawbacks are limited transparency: there is no visible pricing, quality system certification, data security information, or delivery SLA. In addition, there are no apparent enterprise software capabilities such as a cloud platform, APIs, permission management, or third-party integrations.
It is better suited to pharmaceutical companies, biotech/pharma startups, and R&D organizations developing inhaled drugs, nasal products, pMDIs, or related devices, especially those needing external expert support for analytical methods, stability, and CRO/CMO management.
The main website content does not mention accessibility from mainland China, nor does it explain China-based services, language support, or cross-border sample handling processes. This is therefore assessed as unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on inhalytic.com official site.
inhalytic.com is an United Kingdom Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Workable. Click "Visit Official Site" to reach inhalytic.com directly.